Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O2ET
|
||||
Former ID |
DIB004395
|
||||
Drug Name |
AD-5467
|
||||
Synonyms |
Rac-2,8-Bis(1-methylethyl)-3-thioxo-2,3-dihydro-4H-1,4-benzoxazine-4-acetic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Discontinued in Phase 2 | [544842] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H21NO3S
|
||||
Canonical SMILES |
CC(C)C1C(=S)N(C2=CC=CC(=C2O1)C(C)C)CC(=O)O
|
||||
InChI |
1S/C16H21NO3S/c1-9(2)11-6-5-7-12-15(11)20-14(10(3)4)16(21)17(12)8-13(18)19/h5-7,9-10,14H,8H2,1-4H3,(H,18,19)
|
||||
InChIKey |
CLDJCRWXLDLJLO-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 112808-22-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Aldose reductase | Target Info | Inhibitor | [531314], [551871] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References | |||||
Ref 531314 | Studies on antidiabetic agents. IX. A new aldose reductase inhibitor, AD-5467, and related 1,4-benzoxazine and 1,4-benzothiazine derivatives: synthesis and biological activity. Chem Pharm Bull (Tokyo). 1990 May;38(5):1238-45. | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.